DK4051307T3 - Peptid til forebyggelse eller behandling af covid-19 - Google Patents
Peptid til forebyggelse eller behandling af covid-19 Download PDFInfo
- Publication number
- DK4051307T3 DK4051307T3 DK20771826.3T DK20771826T DK4051307T3 DK 4051307 T3 DK4051307 T3 DK 4051307T3 DK 20771826 T DK20771826 T DK 20771826T DK 4051307 T3 DK4051307 T3 DK 4051307T3
- Authority
- DK
- Denmark
- Prior art keywords
- covid
- peptide
- prevention
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/03—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20173713 | 2020-05-08 | ||
| PCT/EP2020/075428 WO2021223894A1 (en) | 2020-05-08 | 2020-09-11 | Peptide for prevention or treatment of covid-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK4051307T3 true DK4051307T3 (da) | 2023-03-27 |
| DK4051307T5 DK4051307T5 (da) | 2024-07-22 |
Family
ID=70680285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK20771826.3T DK4051307T5 (da) | 2020-05-08 | 2020-09-11 | Peptid til forebyggelse eller behandling af covid-19 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250241978A1 (da) |
| EP (1) | EP4051307B1 (da) |
| JP (1) | JP7579356B2 (da) |
| KR (1) | KR20230008844A (da) |
| CN (1) | CN115461356A (da) |
| DK (1) | DK4051307T5 (da) |
| ES (1) | ES2938574T3 (da) |
| IL (1) | IL294894A (da) |
| WO (1) | WO2021223894A1 (da) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4069819A (en) | 1973-04-13 | 1978-01-24 | Societa Farmaceutici S.P.A. | Inhalation device |
| IT1228459B (it) | 1989-02-23 | 1991-06-19 | Phidea S R L | Inalatore con svuotamento regolare e completo della capsula. |
| CA2155103A1 (en) | 1993-02-03 | 1994-08-18 | Rudolph Lucas | Tnf-alpha muteins and a process for preparing them |
| US6260549B1 (en) | 1998-06-18 | 2001-07-17 | Clavius Devices, Inc. | Breath-activated metered-dose inhaler |
| NZ509604A (en) | 1998-08-14 | 2003-05-30 | Innogenetics N | TNF-derived peptides for use in treating oedema |
| CA2441100C (en) | 2001-03-20 | 2013-05-21 | Trudell Medical International | Nebulizer apparatus with an adjustable fluid orifice |
| EP1781323B1 (en) | 2004-08-06 | 2010-02-17 | Nycomed GmbH | Composition comprising a pulmonary surfactant and a tnf-derived peptide |
| EP2009023A1 (en) | 2007-06-04 | 2008-12-31 | Rentschler Beteiligungs GmbH | Novel peptides and their use for the treatment of edema |
| AT507953B1 (de) | 2009-03-05 | 2011-02-15 | Apeptico Forschung & Entwicklung Gmbh | Verfahren zur vermeidung und zur behandlung einer hyperpermeabilität |
| DK2397151T3 (da) | 2010-06-21 | 2015-05-18 | Apeptico Forschung & Entwicklung Gmbh | Behandling af vaskulære komplikationer af diabetes |
| AT510585B1 (de) | 2010-11-18 | 2012-05-15 | Apeptico Forschung & Entwicklung Gmbh | Zusammensetzung umfassend ein peptid und ein hemmstoff der viralen neuraminidase |
| EP2679239A1 (de) | 2012-06-28 | 2014-01-01 | Apeptico Forschung und Entwicklung GmbH | Pharmazeutische Zusammensetzung zur Behandlung der durch Sauerstoffarmut und verringerten Luftdruck vermittelten pulmonalen Form der Höhenkrankheit |
| JP6397984B2 (ja) | 2014-03-18 | 2018-09-26 | アペプティコ・フォルシュング・ウント・エントヴィックルング・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＡｐｅｐｔｉｃｏ Ｆｏｒｓｃｈｕｎｇ Ｕｎｄ Ｅｎｔｗｉｃｋｌｕｎｇ Ｇｍｂｈ | 乾燥粉末ペプチド医薬 |
-
2020
- 2020-09-11 EP EP20771826.3A patent/EP4051307B1/en active Active
- 2020-09-11 CN CN202080100653.0A patent/CN115461356A/zh active Pending
- 2020-09-11 IL IL294894A patent/IL294894A/en unknown
- 2020-09-11 WO PCT/EP2020/075428 patent/WO2021223894A1/en not_active Ceased
- 2020-09-11 KR KR1020227043167A patent/KR20230008844A/ko active Pending
- 2020-09-11 ES ES20771826T patent/ES2938574T3/es active Active
- 2020-09-11 DK DK20771826.3T patent/DK4051307T5/da active
- 2020-09-11 US US17/923,744 patent/US20250241978A1/en active Pending
- 2020-09-11 JP JP2022567567A patent/JP7579356B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP4051307A1 (en) | 2022-09-07 |
| WO2021223894A1 (en) | 2021-11-11 |
| EP4051307B1 (en) | 2023-02-01 |
| IL294894A (en) | 2022-09-01 |
| DK4051307T5 (da) | 2024-07-22 |
| US20250241978A1 (en) | 2025-07-31 |
| JP7579356B2 (ja) | 2024-11-07 |
| CN115461356A (zh) | 2022-12-09 |
| KR20230008844A (ko) | 2023-01-16 |
| JP2023525522A (ja) | 2023-06-16 |
| ES2938574T3 (es) | 2023-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3600281T3 (da) | Kombinationsbehandling til behandling eller forebyggelse af tumorer | |
| EP3689337A4 (en) | NEW RECOMBINANT PLASMIC MEMBRANE VESICLE FOR CANCER TREATMENT | |
| CL2022000531A1 (es) | Composiciones y métodos para el tratamiento de infecciones virales. | |
| DK3785733T3 (da) | Farmaceutisk sammensætning til behandling af autisme | |
| DK3773689T3 (da) | Antigene peptider til forebyggelse og behandling af kræft | |
| DK3658140T3 (da) | Kombinationer af aprocitentan med yderligere aktive bestanddele til behandlingen af resistent hypertension | |
| DK3504210T3 (da) | 7-substituerede sulfonimidoylpurinonforbindelser til behandling og forebyggelse af virusinfektion | |
| DK3759083T3 (da) | 2,4-diaminoquinazolinderivater og anvendelse deraf til behandling af virusinfektioner, cancer eller allergier | |
| DK3509573T3 (da) | Farmaceutiske sammensætninger til indgivelse af peptid | |
| EP3737399A4 (en) | ATF5 PEPTIDIC VARIANTS AND THEIR USES | |
| EP3573620A4 (en) | COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION | |
| DK3269733T3 (da) | Peptid afledt af gpc3, farmaceutisk sammensætning til behandling eller forebyggelse af cancer under anvendelse deraf, immunitetsinducer og fremgangsmåde til fremstilling af antigenpræsenterende celler | |
| EP3877396C0 (en) | POLYPEPTIDES FOR CANCER TREATMENT | |
| EP3740228A4 (en) | PEPTIDES AND THEIR USES | |
| EP4087661A4 (en) | LASSOS PEPTIDES FOR CANCER TREATMENT | |
| DK3618845T3 (da) | Peptider til behandling af diabetes | |
| DK3661490T3 (da) | Sammensætning til anvendelse til forebyggelse og/eller behandling af onkologisk behandlings induceret oroga-strointestinal mucositis | |
| EP3442559C0 (en) | BMP-7 DERIVED PEPTIDES FOR USE IN THE TREATMENT OR PREVENTION OF OSTEOARTHRITIS | |
| DK3561056T3 (da) | Peptid til behandling af aldersrelateret makuladegeneration | |
| IT201700060506A1 (it) | Composizione per la prevenzione e/o il trattamento di patologie associate a infiammazione e/o iperalgesia | |
| DK4218788T3 (da) | Peptider til anvendelse ved behandling af ikke-alkoholisk steatohepatitis | |
| DK4051307T5 (da) | Peptid til forebyggelse eller behandling af covid-19 | |
| DK3648761T3 (da) | Telmisartan til forebyggelsen eller behandlingen af hypertension i katte | |
| EP3686213A4 (en) | PEPTIDE USED TO INHIBIT ANGIOGENESIS AND ITS USE | |
| DK3233110T3 (da) | Cyklisk acetylcholinesterase-c-terminalt peptid i behandling eller forebyggelse af cancer eller metastase |